Collaborate Disseminate
Consuming foods and drinks particularly high in flavonoids – such as berries, tea, dark chocolate and, yes, red wine – could potentially safeguard your brain in older age, with researchers linking these plant-based antioxidants with lowering the risk o… Continue reading Red wine, berries, dark chocolate and tea: A recipe to reduce dementia risk
A new report by world-leading experts lists 14 modifiable risk factors associated with 40% of all dementia cases that, if addressed by people across their lifespan, could reduce the likelihood of developing the condition or delay its onset.
Category: Health & Wellbeing, Lifestyle
Tags: Dementia, Alzheimer’s Disease, Lifespan
Continue reading 14 things you can do to prevent or delay the onset of dementia
An incredible new study has upended our understanding of genetic Alzheimer’s disease, finding that nearly everyone carrying two copies of a culprit gene had distinct biological markers of the degenerative condition by the age of 65. This means the APOE4 gene may no longer merely a risk factor but the driver behind a new stand-alone genetic Alzheimer’s disease type that could impact up to 10 million Americans and more than 200 million people worldwide.
Tags: Alzheimer’s Disease, Dementia, Brain, Age-Related, Disease
Continue reading ‘New’ genetic Alzheimer’s disease may impact 6.7 million Americans
Bigger brains suggest better brain health and cognitive function. And since the 1930s, our brains have been growing in size. Now, a new study shows how this is affecting our risk of developing dementia, particularly Alzheimer’s disease.
Tags: Brain, Dementia, Alzheimer’s Disease, UC Davis, Age-Related
Continue reading Younger generations have bigger brains – and it’s impacting dementia
Researchers have discovered that limiting a certain enzyme can have a dramatic impact in protecting against the effects of Alzheimer’s disease. The finding could lead to a new class of drugs that fight the disease.
Tags: Alzheimer’s Disease, Lancaster University, University of Leeds, Dementia, Neuroscience, Brain
Continue reading Beyond plaques: New Alzheimer’s treatment pathway discovered
Using an AI-based approach, researchers found a better way to create the drug galantamine, commonly prescribed to people suffering from Alzheimer’s and other forms of dementia. The fermentation-based technique could boost the drug’s availability.
Tags: Alzheimer’s Disease, Dementia, Bacteria, Microbes, University of Texas
Continue reading Microbes stomp daffodils in creating valuable anti-Alzheimer’s drug
Air pollution in urban environments has long been associated with poor health. Breast cancer, immune dysfunction, osteoporosis, heart problems and dementia have all been linked to air pollution, however, understanding exactly how poor air quality is explicitly causing disease has been a challenge for researchers.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Dementia, Air quality, Pollution
Continue reading Magnetite pollution is damaging our brains and causing Alzheimer’s
Even mild cases of COVID cause significant, measurable cognitive deficits compared to those never infected with the virus, according to one of the largest studies of its type. COVID brain fog is real, and it can sap up to six IQ points for at least a y… Continue reading COVID brain fog drains 3-6 IQ points for more than a year
Infection with the virus that’s the main cause of cold sores may double a person’s risk of developing dementia, according to a new study. Adding to growing evidence of a link between the two, further research is needed to investigate whether anti-herpe… Continue reading Dementia risk doubled by common herpes virus, study finds
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
Tags: University of Toronto, Ozempic, GLP1, Alzheimer’s Disease, Parkinson’s Disease, Inflammatory, Brain, Dementia
Continue reading GLP-1 weight-loss drugs may pivot to treat Alzheimer’s and Parkinson’s